Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: ALGN SYK JNJ ISRG BSX ZBH MDT BAX HOLX STE

| Held by: VTI VOO VB VBR IVV SPY RSP XLV IWR VHT

Index	S&P 500	P/E	44.29	EPS (ttm)	1.87	Insider Own	0.68%	Shs Outstand	195.90M	Perf Week	1.08%
Market Cap	16.26B	Forward P/E	16.75	EPS next Y	4.96	Insider Trans	2.62%	Shs Float	194.64M	Perf Month	1.59%
Enterprise Value	18.94B	PEG	1.69	EPS next Q	1.03	Inst Own	109.25%	Short Float	4.18%	Perf Quarter	14.48%
Income	374.90M	P/S	3.97	EPS this Y	9.73%	Inst Trans	2.78%	Short Ratio	3.06	Perf Half Y	13.00%
Sales	4.09B	P/B	1.97	EPS next Y	9.61%	ROA	3.03%	Short Interest	8.13M	Perf YTD	1.26%
Book/sh	42.06	P/C	147.05	EPS next 5Y	9.90%	ROE	4.59%	52W High	94.17 -11.87%	Perf Year	-11.41%
Cash/sh	0.56	P/FCF	37.50	EPS past 3/5Y	-1.15% 9.30%	ROIC	3.43%	52W Low	61.78 34.34%	Perf 3Y	-1.90%
Dividend Est.	-	EV/EBITDA	17.86	Sales past 3/5Y	7.35% 10.98%	Gross Margin	60.67%	Volatility	2.50% 2.15%	Perf 5Y	-13.87%
Dividend TTM	-	EV/Sales	4.63	EPS Y/Y TTM	-4.47%	Oper. Margin	16.69%	ATR (14)	1.95	Perf 10Y	148.51%
Dividend Ex-Date	Jul 26, 2023	Quick Ratio	1.13	Sales Y/Y TTM	5.06%	Profit Margin	9.16%	RSI (14)	56.28	Recom	2.14
Dividend Gr. 3/5Y	- -	Current Ratio	1.89	EPS Q/Q	-26.90%	SMA20	2.00%	Beta	1.02	Target Price	90.56
Payout	0.00%	Debt/Eq	0.34	Sales Q/Q	4.60%	SMA50	1.71%	Rel Volume	0.82	Prev Close	81.70
Employees	15000	LT Debt/Eq	0.33	Earnings	Mar 05 AMC	SMA200	10.99%	Avg Volume	2.66M	Price	82.99
IPO	Jan 21, 1983	Option/Short	Yes / Yes	EPS/Sales Surpr.	3.30% 0.42%	Trades		Volume	2,176,416	Change	1.58%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-03-26	Reiterated	Needham	Buy	$100 → $99
Nov-13-25	Downgrade	Wells Fargo	Overweight → Equal Weight	$72
Oct-13-25	Initiated	Barclays	Overweight	$85
Oct-01-25	Initiated	Goldman	Sell	$64
Aug-28-25	Downgrade	Citigroup	Buy → Neutral	$72
Jul-22-25	Upgrade	BNP Paribas Exane	Neutral → Outperform	$92
Jun-17-25	Upgrade	Needham	Hold → Buy	$94
May-30-25	Downgrade	JP Morgan	Overweight → Neutral	$76
Aug-29-24	Reiterated	Piper Sandler	Overweight	$115 → $120
Jul-16-24	Upgrade	Jefferies	Hold → Buy	$107 → $115
Mar-19-24	Upgrade	Redburn Atlantic	Neutral → Buy	$125
Mar-13-24	Upgrade	JP Morgan	Neutral → Overweight	$100 → $120
Feb-06-24	Resumed	KeyBanc Capital Markets	Sector Weight
Oct-30-23	Initiated	BofA Securities	Buy	$380
Oct-05-23	Downgrade	Redburn Atlantic	Overweight → Neutral	$390 → $343
May-30-23	Initiated	Morgan Stanley	Equal-Weight	$410
Dec-22-22	Initiated	Mizuho	Buy	$375
Nov-30-22	Upgrade	Robert W. Baird	Neutral → Outperform	$345 → $375
Oct-12-22	Downgrade	Jefferies	Buy → Hold	$400 → $295
Aug-29-22	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight

Show Previous Ratings

Feb-13-26 11:40AM	COO vs. WST: Which Stock Is the Better Value Option? (Zacks)
Feb-11-26 01:34PM	BD Merges Biosciences & Diagnostics Business With Waters (Zacks)
Feb-10-26 09:23AM	The Cooper Companies (COO) Moved Higher as Multiple Tailwinds Align (Insider Monkey)
Feb-05-26 04:15PM	CooperCompanies Announces Release Date for First Quarter 2026 (GlobeNewswire)
Feb-04-26 05:20PM	Align Technology (ALGN) Surpasses Q4 Earnings and Revenue Estimates (Zacks)
01:17PM	Loading…
Feb-03-26 01:17PM	Reasons to Add Cooper Companies Stock to Your Portfolio Now (Zacks)
12:10PM	Will The Cooper Companies (COO) Beat Estimates Again in Its Next Earnings Report? (Zacks)
08:05AM	Diamond Hill Large Cap Fund Purchased Cooper Companies (COO) Betting on the Resilient Contact Lens Industry (Insider Monkey)
Feb-02-26 11:57AM	BD & Envetec Showcase Closed-Loop Recycling Solution for Lab Plastics (Zacks)
Jan-29-26 11:38PM	1 Healthcare Stock to Own for Decades and 2 We Question (StockStory)
12:17PM	CONMED Stock Up Post Q4 Earnings and Revenue Beat, Gross Margin Up (Zacks)
Jan-28-26 11:40AM	COO vs. WST: Which Stock Should Value Investors Buy Now? (Zacks)
Jan-27-26 12:19PM	Here's Why You Should Add Merit Medical Stock to Your Portfolio Now (Zacks)
09:45AM	Why The Cooper Companies (COO) is a Top Growth Stock for the Long-Term (Zacks)
Jan-26-26 09:40AM	Here's Why The Cooper Companies (COO) is a Strong Value Stock (Zacks)
01:50PM	Loading…
Jan-23-26 01:50PM	WST Launches Synchrony S1 Prefillable Syringe at Pharmapack (Zacks)
07:57AM	What You Need to Know Ahead of The Cooper Companies' Earnings Release (Barchart)
Jan-22-26 11:08AM	Here's Why You Should Retain Integer Holdings Stock in Your Portfolio (Zacks)
10:43AM	BD and Ypsomed Expand Partnership to Target Growing Biologics Market (Zacks)
Jan-21-26 11:43AM	BD Gets FDA 510(k) Approval for EnCor EnCompass Breast Biopsy System (Zacks)
Jan-14-26 12:50PM	Reasons to Add West Pharmaceutical Stock to Your Portfolio Now (Zacks)
Jan-13-26 11:16AM	Judge Denies Teva Bid To Pause Paragard Copper Contraceptive Device Lawsuit Trial (Benzinga)
Jan-12-26 11:40AM	COO or WST: Which Is the Better Value Stock Right Now? (Zacks)
Jan-07-26 03:00PM	40 stocks likely to outperform in 2026: Boyar pres. explains (Yahoo Finance Video)
Jan-06-26 08:00AM	CooperVision to Launch MyDay MiSight 1 day Myopia Control Soft Contact Lenses (PR Newswire)
Jan-05-26 07:17AM	Hologic Trading Near 52-Week High: How Should You Play the Stock? (Zacks)
Jan-01-26 10:32PM	Medical Devices & Supplies - Diversified Stocks Q3 In Review: CooperCompanies (NASDAQ:COO) Vs Peers (StockStory)
Dec-31-25 07:36AM	What Makes The Cooper Companies (COO) an Investment Bet? (Insider Monkey)
Dec-30-25 02:04PM	Top Stock Reports for Berkshire Hathaway, AstraZeneca & Intel (Zacks)
07:33AM	Reasons to Add Cooper Companies Stock to Your Portfolio Now (Zacks)
04:15PM	Loading…
Dec-29-25 04:15PM	CooperCompanies to Present at the J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-26-25 11:40AM	COO vs. MMSI: Which Stock Is the Better Value Option? (Zacks)
Dec-23-25 08:00AM	CooperCompanies Appoints Walter M Rosebrough, Jr. to its Board of Directors (GlobeNewswire)
Dec-22-25 12:12PM	BD and Penn Institute Ink Collaboration to Advance Immunotherapy (Zacks)
Dec-19-25 09:55AM	The Cooper Companies (COO)'s Technical Outlook is Bright After Key Golden Cross (Zacks)
Dec-16-25 11:05PM	3 Reasons to Sell COO and 1 Stock to Buy Instead (StockStory)
11:37AM	BD Expands BD MAX With IVDR-Approved VIASURE Tests in Europe (Zacks)
Dec-12-25 09:50AM	Why The Cooper Companies (COO) is a Top Momentum Stock for the Long-Term (Zacks)
Dec-11-25 07:34AM	Is The Cooper Companies Stock Underperforming the Nasdaq? (Barchart)
12:31AM	5 Insightful Analyst Questions From CooperCompanies's Q3 Earnings Call (StockStory)
Dec-10-25 11:40AM	COO or MMSI: Which Is the Better Value Stock Right Now? (Zacks)
Dec-08-25 09:40AM	Why The Cooper Companies (COO) is a Top Value Stock for the Long-Term (Zacks)
09:15AM	The Cooper Companies (COO) International Revenue Performance Explored (Zacks)
Dec-05-25 11:11AM	CooperCompanies (COO) Stock Trades Up, Here Is Why (StockStory) +5.67%
11:02AM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research)
09:11AM	COO Gains as Q4 Earnings & Sales Beat Estimates, MyDay Adoption Rises (Zacks)
07:36AM	Warner Bros. shares rise on Netflix deal news, Hewlett Packard Enterprise slumps on earnings and more early market movers (MarketWatch)
02:46AM	Stock Market Today: Dow, S&P 500 and Nasdaq point to gains as investors await Fed's preferred inflation gauge; bitcoin slips, silver surges (MarketWatch)
12:31AM	COO Q3 Deep Dive: Product Momentum and Strategic Review Shape Outlook (StockStory)
12:02AM	The Cooper Companies Inc (COO) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com)
Dec-04-25 06:30PM	The Cooper Companies (COO) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:25PM	The Cooper Companies (COO) Q4 Earnings and Revenues Surpass Estimates (Zacks)
04:45PM	CooperCompanies (NASDAQ:COO) Reports Q3 CY2025 In Line With Expectations, Stock Soars (StockStory)
04:20PM	CooperCompanies Announces New Chair of the Board and Strategic Review (GlobeNewswire)
04:15PM	CooperCompanies Announces Fourth Quarter and Full Year 2025 Results (GlobeNewswire)
Dec-03-25 05:15PM	HealthEquity (HQY) Tops Q3 Earnings and Revenue Estimates (Zacks)
12:45PM	Cooper Companies to Post Q4 Earnings: What's in Store for the Stock? (Zacks)
Dec-02-25 10:04PM	What To Expect From CooperCompanies's (COO) Q3 Earnings (StockStory)
Dec-01-25 09:15AM	Curious about The Cooper Companies (COO) Q4 Performance? Explore Wall Street Estimates for Key Metrics (Zacks)
06:11AM	1 Profitable Stock to Own for Decades and 2 We Find Risky (StockStory)
Nov-30-25 07:27AM	Stocks drift back towards record highs as the final month of 2025 gets underway: What to watch this week (Yahoo Finance)
07:27AM	Stocks drift back toward record highs as the final month of 2025 gets underway: What to watch this week (Yahoo Finance)
Nov-27-25 10:00AM	The Cooper Companies (COO) Earnings Expected to Grow: Should You Buy? (Zacks)
Nov-23-25 11:36PM	1 Healthcare Stock Worth Your Attention and 2 Facing Headwinds (StockStory)
Nov-21-25 06:36PM	CooperCompanies, iRhythm, Baxter, Omnicell, and Neogen Shares Skyrocket, What You Need To Know (StockStory) +6.13%
Nov-19-25 06:38AM	Cooper Companies Stock: Analyst Estimates & Ratings (Barchart)
Nov-14-25 05:10PM	Jana Partners' Strategic Move: Significant Addition of The Cooper Companies Inc (GuruFocus.com)
Nov-13-25 05:20PM	Aytu BioPharma Inc. (AYTU) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
09:45AM	Nike upgraded, Dollar Tree downgraded: Wall Street's top analyst calls (The Fly)
09:10AM	Here Are Thursdays Top Wall Street Analyst Research Calls: AbbVie, AppLovin, Autozone, Booking Holdings, CoreWeave, DoorDash, and More (24/7 Wall St.)
Nov-06-25 07:40AM	Becton Dickinson (BDX) Tops Q4 Earnings and Revenue Estimates (Zacks)
Nov-05-25 06:30PM	Conmed (CNMD) Tops Q3 Earnings and Revenue Estimates (Zacks)
Nov-04-25 04:15PM	CooperCompanies Announces Release Date for Fourth Quarter and Full Year 2025 (GlobeNewswire)
Nov-03-25 12:00PM	Can Sustained Product Demand Drive BDX Stock Before Q4 Earnings? (Zacks)
Oct-31-25 10:23AM	4 Resilient Dental Supply Players Positioned to Withstand Tariff Risks (Zacks)
Oct-28-25 01:54AM	What to Expect From Cooper Companies Next Quarterly Earnings Report (Barchart)
Oct-21-25 09:24AM	Company News for Oct 21, 2025 (Zacks)
Oct-20-25 09:34AM	Stocks to Watch Monday: Amazon, Zions Bancorp, Kering (The Wall Street Journal)
08:21AM	5 Things to Know Before the Stock Market Opens (Investopedia)
07:41AM	Cooper Cos. Stock Rises as Report Says Activist Investor Takes Stake (Barrons.com)
07:25AM	Activist Jana Pushes Big Contact-Lens Combination of Cooper and Bausch + Lomb (The Wall Street Journal)
Oct-19-25 08:00PM	Activist Jana Takes Stake in Cooper, a Maker of Medical Devices (The Wall Street Journal)
Oct-16-25 09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Oct-01-25 11:01AM	Goldman Sachs initiates ophthalmology coverage: Buy Glaukos, sell Cooper (Investing.com)
Sep-26-25 11:30AM	The Cooper Companies (COO) Up 3.6% Since Last Earnings Report: Can It Continue? (Zacks)
12:39AM	3 Healthcare Stocks That Fall Short (StockStory)
Sep-22-25 09:46AM	Reasons to Retain Cooper Companies Stock in Your Portfolio for Now (Zacks)
Sep-19-25 01:55AM	Is Cooper Companies Stock Underperforming the S&P 500? (Barchart)
Sep-18-25 11:42AM	Why CooperCompanies (COO) Stock Is Up Today (StockStory)
Sep-17-25 04:15PM	CooperCompanies Announces Expanded Share Repurchase Program (GlobeNewswire)
Sep-15-25 09:40AM	Here's Why The Cooper Companies (COO) is a Strong Value Stock (Zacks)
Sep-09-25 12:02AM	3 Reasons COO is Risky and 1 Stock to Buy Instead (StockStory)
Sep-03-25 01:31AM	5 Insightful Analyst Questions From CooperCompanies's Q2 Earnings Call (StockStory)
Sep-02-25 03:30PM	Why CooperCompanies (COO) Shares Are Falling Today (StockStory)
Sep-01-25 09:15AM	Interpreting The Cooper Companies (COO) International Revenue Trends (Zacks)
Aug-31-25 11:34PM	Medical Devices & Supplies - Diversified Stocks Q2 Recap: Benchmarking CooperCompanies (NASDAQ:COO) (StockStory)
Aug-29-25 09:47AM	COO Q3 Earnings Beat, 2025 Sales Outlook Lowered, Stock Down (Zacks)
09:40AM	Why The Cooper Companies (COO) is a Top Value Stock for the Long-Term (Zacks)
Aug-28-25 05:28PM	Why Cooper Companies Stock Sank by 13% Today (Motley Fool) -12.85%
04:25PM	These Stocks Moved the Most Today: Nvidia, Snowflake, Pure Storage, CrowdStrike, Hormel Foods, Cooper, HP, and More (Barrons.com)

The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Jay Colleen	Director	Jan 12 '26	Option Exercise	39.40	7,064	278,322	36,585	Jan 14 04:05 PM
White Albert G III	President & CEO	Jan 08 '26	Option Exercise	0.00	18,340	0	254,491	Jan 12 04:24 PM
Warner Gerard H III	President, CooperVision, Inc.	Jan 08 '26	Option Exercise	0.00	11,518	0	29,837	Jan 12 04:24 PM
Sheffield Holly R	President, CSI	Jan 08 '26	Option Exercise	0.00	8,050	0	47,102	Jan 12 04:23 PM
McBride Daniel G	EVP & Chief Operating Officer	Jan 08 '26	Option Exercise	0.00	12,887	0	76,007	Jan 12 04:23 PM
Andrews Brian G	EVP, CFO & Treasurer	Jan 08 '26	Option Exercise	0.00	3,528	0	10,430	Jan 12 04:22 PM
Lucchese Cynthia L	Director	Dec 22 '25	Buy	84.06	1,784	149,963	9,445	Dec 23 04:08 PM
Rivas Maria	Director	Dec 18 '25	Buy	82.13	1,000	82,130	11,141	Dec 19 04:18 PM
Kurzius Lawrence Erik	Director	Dec 17 '25	Buy	82.50	2,000	165,000	7,777	Dec 17 05:06 PM
Sheffield Holly R	President, CSI	Dec 16 '25	Buy	80.75	1,230	99,322	39,052	Dec 16 06:36 PM
White Albert G III	President & CEO	Dec 16 '25	Buy	80.80	10,000	808,000	236,151	Dec 16 06:36 PM
Kurzius Lawrence Erik	Director	Sep 29 '25	Buy	68.39	2,000	136,780	5,777	Sep 29 08:36 PM
White Albert G III	President & CEO	Sep 05 '25	Buy	68.39	10,000	683,900	226,151	Sep 05 05:10 PM
Warner Gerard H III	President, CooperVision, Inc.	Sep 05 '25	Buy	69.23	1,450	100,384	18,319	Sep 05 04:07 PM
McBride Daniel G	EVP & Chief Operating Officer	Sep 02 '25	Buy	65.04	3,000	195,120	63,120	Sep 02 05:17 PM
Andrews Brian G	EVP, CFO & Treasurer	Sep 02 '25	Buy	65.68	1,525	100,162	22,191	Sep 02 05:16 PM
KOZY WILLIAM A	Director	Apr 01 '25	Option Exercise	0.00	2,857	0	31,149	Apr 03 04:09 PM
WEISS ROBERT S	Director	Apr 01 '25	Option Exercise	0.00	2,993	0	288,945	Apr 03 04:09 PM
Rivas Maria	Director	Apr 01 '25	Option Exercise	0.00	2,721	0	2,721	Apr 03 04:08 PM
MADDEN TERESA S	Director	Apr 01 '25	Option Exercise	0.00	2,721	0	12,357	Apr 03 04:08 PM
Lucchese Cynthia L	Director	Apr 01 '25	Option Exercise	0.00	2,721	0	7,661	Apr 03 04:07 PM
Kurzius Lawrence Erik	Director	Apr 01 '25	Option Exercise	0.00	2,721	0	3,777	Apr 03 04:07 PM
Jay Colleen	Director	Apr 01 '25	Option Exercise	0.00	2,721	0	29,521	Apr 03 04:06 PM
Ricupati Agostino	SVP & CAO	Apr 01 '25	Option Exercise	0.00	2,076	0	9,044	Apr 03 04:06 PM

Open in Screener

MKC

McCormick & Co., Inc

Feb 13 • 04:00PM ET

71.49

-0.16 -0.22 %

Consumer Defensive • Packaged Foods • USA • NYSE

MKC McCormick & Co., Inc daily Stock Chart

Peers: CHD HRL SYY K GIS KHC CPB MDLZ CAG PEP

| Held by: VTI VOO VO IVV SPY XLP SDY RSP NOBL VTV

Index	S&P 500	P/E	24.37	EPS (ttm)	2.93	Insider Own	6.27%	Shs Outstand	253.50M	Perf Week	6.04%
Market Cap	19.20B	Forward P/E	21.31	EPS next Y	3.35	Insider Trans	-1.53%	Shs Float	251.62M	Perf Month	4.26%
Enterprise Value	23.36B	PEG	3.11	EPS next Q	0.62	Inst Own	83.71%	Short Float	4.64%	Perf Quarter	8.52%
Income	789.40M	P/S	2.81	EPS this Y	3.27%	Inst Trans	3.01%	Short Ratio	3.36	Perf Half Y	1.85%
Sales	6.84B	P/B	3.34	EPS next Y	8.26%	ROA	6.01%	Short Interest	11.68M	Perf YTD	4.96%
Book/sh	21.37	P/C	200.17	EPS next 5Y	6.85%	ROE	14.32%	52W High	86.24 -17.10%	Perf Year	-7.77%
Cash/sh	0.36	P/FCF	25.93	EPS past 3/5Y	5.10% 1.08%	ROIC	8.76%	52W Low	59.62 19.91%	Perf 3Y	-5.42%
Dividend Est.	1.92 (2.68%)	EV/EBITDA	17.64	Sales past 3/5Y	2.51% 4.08%	Gross Margin	37.90%	Volatility	2.61% 3.06%	Perf 5Y	-20.26%
Dividend TTM	1.83 (2.56%)	EV/Sales	3.41	EPS Y/Y TTM	0.10%	Oper. Margin	15.97%	ATR (14)	1.86	Perf 10Y	59.45%
Dividend Ex-Date	Dec 29, 2025	Quick Ratio	0.28	Sales Y/Y TTM	1.73%	Profit Margin	11.54%	RSI (14)	67.32	Recom	2.24
Dividend Gr. 3/5Y	6.74% 7.74%	Current Ratio	0.70	EPS Q/Q	5.45%	SMA20	9.26%	Beta	0.57	Target Price	73.64
Payout	61.43%	Debt/Eq	0.74	Sales Q/Q	2.91%	SMA50	7.72%	Rel Volume	1.17	Prev Close	71.65
Employees	14100	LT Debt/Eq	0.57	Earnings	Jan 22 BMO	SMA200	3.35%	Avg Volume	3.48M	Price	71.49
IPO	Mar 17, 1980	Option/Short	Yes / Yes	EPS/Sales Surpr.	-1.85% 0.31%	Trades		Volume	4,073,808	Change	-0.22%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-15-25	Upgrade	Deutsche Bank	Hold → Buy	$75
Aug-20-25	Upgrade	JP Morgan	Neutral → Overweight	$83
Jun-16-25	Initiated	UBS	Neutral	$83
Mar-27-25	Downgrade	Argus	Buy → Hold
Jan-08-25	Upgrade	TD Cowen	Hold → Buy	$86 → $90
Dec-09-24	Upgrade	Jefferies	Hold → Buy	$85 → $91
Jun-12-24	Upgrade	Citigroup	Sell → Neutral	$68 → $69
Apr-02-24	Upgrade	Argus	Hold → Buy
Feb-01-24	Initiated	Citigroup	Sell	$60
Jan-22-24	Downgrade	Consumer Edge Research	Overweight → Equal Weight
Sep-22-23	Initiated	HSBC Securities	Hold	$86
Sep-13-23	Initiated	TD Cowen	Market Perform	$87
Jun-06-23	Upgrade	BofA Securities	Underperform → Buy	$75 → $100
Apr-14-23	Resumed	Stifel	Hold	$82
Mar-10-23	Initiated	UBS	Sell	$71
Jan-27-23	Upgrade	Bernstein	Mkt Perform → Outperform	$90
Nov-15-22	Initiated	Exane BNP Paribas	Outperform	$94
Jul-06-22	Downgrade	Argus	Buy → Hold
Feb-17-22	Upgrade	Argus	Hold → Buy	$112
Jan-19-22	Downgrade	Credit Suisse	Outperform → Neutral	$100

Show Previous Ratings

Feb-13-26 07:00PM	3 Highest-yielding Dividend Aristocrats That'll Pay You For Generations (Barchart)
Feb-12-26 08:34AM	Is Wall Street Bullish or Bearish on McCormick & Company Stock? (Barchart)
Feb-10-26 01:44PM	Analyst Report: McCormick & Company, Incorporated (Morningstar Research)
08:43AM	UBS Reduces PT on McCormick & Company (MKC) Stock (Insider Monkey)
Feb-08-26 11:02PM	McCormick (MKC): Buy, Sell, or Hold Post Q4 Earnings? (StockStory)
09:05AM	Loading…
Feb-03-26 09:05AM	Barclays Reviews McCormick (MKC) as ERP and Tax Pressures Come Into Focus (Insider Monkey)
Jan-30-26 04:32AM	McCormick tackles $50M tariff hit through pricing, other measures (Supply Chain Dive)
Jan-29-26 03:44PM	The Earnings Impact of Tariffs (Zacks)
12:34AM	The Top 5 Analyst Questions From McCormick's Q4 Earnings Call (StockStory)
Jan-27-26 05:53PM	BofA Stays Positive on McCormick (MKC) Despite Weaker Q4 Results (Insider Monkey)
Jan-26-26 04:30PM	McCormick & Company to Present at Consumer Analyst Group of New York Conference (PR Newswire)
Jan-25-26 08:00AM	Are consumer staples stocks still worth investing in? (Yahoo Finance Video)
Jan-23-26 02:15PM	Your Favorite Spices May Get a Bit More Expensive Soon. Here's the Reason Why (Investopedia)
01:09PM	CEOs Flag Jittery US Consumers as Global Tensions Intensify (Bloomberg)
09:07AM	McCormick Q4 Earnings Lag Estimates, Organic Sales Grow (Zacks)
08:58AM	Loading…
08:58AM	Company News for Jan 23, 2026 (Zacks)
12:32AM	MKC Q4 Deep Dive: Margin Pressures Offset Modest Sales Growth as Guidance Clouds Outlook (StockStory)
Jan-22-26 04:36PM	Stocks Settle Higher as Global Tensions Cool and the Economy Expands (Barchart) -8.05%
03:50PM	Meta's bullish call, Alibaba's AI chip unit, McCormick earnings (Yahoo Finance Video)
03:31PM	Analyst Report: McCormick & Company, Incorporated (Morningstar Research)
03:06PM	Russell 2000 Extends Records, Meta Jumps 5%: What's Moving Markets Thursday? (Benzinga)
02:10PM	McCormick Raises Prices as Higher Costs Hurt Profitability (The Wall Street Journal)
02:01PM	McCormick & Co Inc (MKC) Q4 2025 Earnings Call Highlights: Navigating Growth Amid Inflation ... (GuruFocus.com)
01:47PM	Procter & Gamble Q2 Earnings Beat Estimates, Organic Sales Flat Y/Y (Zacks)
01:08PM	McCormick & Company, Incorporated Q4 Earnings Call Highlights (MarketBeat)
12:56PM	Why McCormick (MKC) Stock Is Nosediving (StockStory)
12:30PM	Medifast's Q4 Guidance Remains Weak: When Does Growth Return? (Zacks)
11:40AM	KRYAY or MKC: Which Is the Better Value Stock Right Now? (Zacks)
10:58AM	Spice Giant McCormick Stumbles, CEO Blames Inflation, Tariffs (Benzinga)
10:19AM	Spice Maker McCormick Plans to Raise Prices Further to Offset Tariffs (The Wall Street Journal)
09:41AM	Loading…
09:41AM	Stocks to Watch Thursday: Intel, P&G, GE Aerospace (The Wall Street Journal)
09:30AM	Compared to Estimates, McCormick (MKC) Q4 Earnings: A Look at Key Metrics (Zacks)
08:59AM	Service Corporation's Strategic Focus: What's Driving Stability Now? (Zacks)
08:20AM	McCormick Logs Higher Sales, Gives Soft Full-Year 2026 Outlook (The Wall Street Journal)
07:40AM	McCormick (MKC) Lags Q4 Earnings and Revenue Estimates (Zacks)
07:26AM	This Spice Maker's Stock Is Tumbling After Earnings. What We Know. (Barrons.com)
07:26AM	McCormick Logs Higher Quarterly Sales, Projects Continued Annual Growth (The Wall Street Journal)
06:48AM	McCormick: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
06:46AM	McCormick's (NYSE:MKC) Q4 CY2025 Sales Top Estimates But Stock Drops (StockStory)
06:30AM	McCORMICK REPORTS STRONG 2025 FINANCIAL RESULTS AND PROVIDES 2026 OUTLOOK (PR Newswire)
Jan-21-26 07:00PM	Trump EU meeting, Intel earnings, December PCE: What to Watch (Yahoo Finance Video)
04:15PM	McCormick Appoints Gavin Hattersley and Rick Dierker to Board of Directors (PR Newswire)
01:21PM	Brown-Forman Advances on Strong Brands and Premiumization (Zacks)
10:34AM	Can B&G Foods' Margin Improvement Hold Amid Soft Demand? (Zacks)
08:57AM	Hormel Foods International Sales: Still a Growth Engine? (Zacks)
Jan-20-26 10:07PM	McCormick (MKC) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
12:27PM	Can Boston Beer's Margin Surge Compensate for Soft Volume Trends? (Zacks)
11:28AM	McCormick Q4 Earnings Coming Up: What Investors Need to Understand (Zacks)
11:02AM	Jim Cramer on McCormick: "I Frankly Don't Know If It's Capable of Really Beating the Numbers Anymore" (Insider Monkey)
Jan-18-26 07:30AM	Trump in Davos, Netflix and Intel results on deck earnings season ramps: What to watch this week (Yahoo Finance)
07:30AM	Trump in Davos, Netflix and Intel results on deck as earnings season ramps: What to watch this week (Yahoo Finance)
07:30AM	Trump in Davos, Netflix and Intel results on deck as earnings season ramps up: What to watch this week (Yahoo Finance)
Jan-16-26 07:00PM	Trump at Davos, Netflix earnings, SCOTUS hearing: What to Watch (Yahoo Finance Video)
12:30PM	Why Clorox Stock Remains Worth Holding in Your Portfolio Now? (Zacks)
09:15AM	Seeking Clues to McCormick (MKC) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics (Zacks)
09:09AM	Beyond Meat Builds on Protein Strengths With Launch of Beyond Immerse (Zacks)
08:14AM	How Is B&G Foods Reshaping Its Brand Portfolio for Growth? (Zacks)
Jan-15-26 12:20PM	Is Constellation Brands Poised to Gain Share Amid Category Headwinds? (Zacks)
10:04AM	AB InBev Bolsters Position With Premiumization and Digital Expansion (Zacks)
10:00AM	McCormick (MKC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
09:47AM	Can Brand Diversification Shield PPC From Commodity Volatility? (Zacks)
Jan-14-26 10:52AM	Can McCormick's Innovation & Distribution Wins Offset Cost Pressures? (Zacks)
Jan-13-26 12:01PM	Is Colgate's Cost Discipline Enough in a Softer Demand Cycle? (Zacks)
09:53AM	Can Tyson Foods' Chicken Segment Drive Consistent Profit Growth? (Zacks)
09:01AM	Are Sysco's U.S. Foodservice Operations Gaining Executional Traction? (Zacks)
Jan-12-26 08:55AM	J.M. Smucker's Pet Food Sales Soft: Is Demand Normalizing Yet? (Zacks)
Jan-09-26 12:30PM	SMPL Stock Jumps 7% After Posting Earnings & Sales Beat in Q1 (Zacks)
08:04AM	HELE Q3 Earnings Meet Estimates, Home & Outdoor Sales Decline Y/Y (Zacks)
07:57AM	Service Corporation Revenue Mix: What's Powering the Top Line? (Zacks)
07:39AM	Lamb Weston Streamlines Global Footprint to Improve Efficiency (Zacks)
Jan-08-26 12:52PM	Medifast Shifts to Metabolic Health: A Durable Growth Path? (Zacks)
10:27AM	Constellation Brands Posts Q3 Earnings Beat, Soft Wine & Spirits Sales (Zacks)
09:38AM	Church & Dwight Accelerates Innovation to Defend Market Share (Zacks)
09:12AM	United Natural Foods' Natural vs. Conventional: Margin Divide Widens? (Zacks)
09:00AM	Flowers Foods Faces Margin Pressure: Can Profitability Recover? (Zacks)
06:22AM	McCormick to Invest $750 Million for Majority Control of Mexican Joint Venture (GuruFocus.com)
Jan-06-26 11:07AM	McCormick Takes Majority Control in Mexico JV: Growth Lever in 2026? (Zacks)
Jan-02-26 04:00PM	McCormick Completes Acquisition of Controlling Interest in McCormick de Mexico (PR Newswire)
Dec-31-25 11:33PM	3 S&P 500 Stocks We Keep Off Our Radar (StockStory)
Dec-29-25 08:41PM	Analyst Report: McCormick & Company, Incorporated (Morningstar Research)
Dec-23-25 06:34AM	McCormick & Company's Quarterly Earnings Preview: What You Need to Know (Barchart)
Dec-22-25 09:00AM	McCormick & Company to Report 2025 Fourth Quarter Financial Results on January 22, 2026 (PR Newswire)
Dec-21-25 05:30AM	Makers of Everyday Essentials Once Offered Investors Safety. Do They Still? (The Wall Street Journal)
Dec-15-25 10:35PM	Reflecting On Shelf-Stable Food Stocks' Q3 Earnings: McCormick (NYSE:MKC) (StockStory)
10:20AM	McCormick's Q3 Volumes Gain Traction: What to Expect in 2026? (Zacks)
09:16AM	Here Are Mondays Top Wall Street Analyst Research Calls: Bristol-Myers Squibb, GE Vernova, KLA Corp., Klaviyo, Las Vegas Sands, ServiceNow, and More (24/7 Wall St.)
Dec-11-25 03:10AM	How Is McCormicks Stock Performance Compared to Other Food & Beverage Stocks? (Barchart)
Dec-02-25 11:03PM	3 Reasons to Avoid MKC and 1 Stock to Buy Instead (StockStory)
12:40PM	MKC's Q3 Shows Solid Consumer Momentum: Will the Strength Last in 2026? (Zacks)
Dec-01-25 03:49PM	3 Fresh Dividend Hikes That Might Be Telling You Something (MarketBeat)
Nov-26-25 10:14AM	Flavor Solutions Lifts MKC's Q3 Results: Will the Growth Last? (Zacks)
Nov-19-25 08:00AM	McCormick Raises Quarterly Dividend: A Look at Its Growth Strategy (Zacks)
Nov-18-25 11:38PM	1 Cash-Producing Stock Worth Investigating and 2 We Turn Down (StockStory)
06:14PM	What's on the Thanksgiving Table? A Stock Pick for Every Course (MarketBeat)
04:50PM	McCormick Announces Increase in Quarterly Dividend (PR Newswire)
10:57AM	Will McCormick Be Able to Sustain Its 2% Organic Growth in 2026? (Zacks)
Nov-17-25 09:29AM	JPMorgan sees major EPS tailwinds for these food producers from new tariff relief (Investing.com)
Nov-13-25 04:15PM	Are Wall Street Analysts Bullish on McCormick & Company Stock? (Barchart)
Nov-12-25 07:00AM	Sick of hearing about the AI trade? BofA offers 16 hot stock picks that go far beyond tech. (MarketWatch)
06:00AM	BofA says AI excitement is eclipsing other investing opportunities (Yahoo Finance)

McCormick & Co., Inc. engages in the manufacturing, marketing, and distribution of spices, seasoning mixes, condiments, and other flavorful products to retail outlets, food manufacturers, and foodservice businesses. The firm offers the Aeroplane, Billy Bee, Cattlemen's BBQ Sauce, Cholula, Club House, Club House for Chefs, Drogheria & Alimentari, Ducros, El Guapo, FONA, Frank's RedHot, French's, and other related brands. It operates through the Consumer and Flavor Solutions segments. The Consumer segment sells spices, seasonings, condiments, and sauces. The Flavor Solutions segment includes seasoning blends, spices and herbs, condiments, coating systems, and compound flavors. The company was founded by Willoughby M. McCormick in 1889 and is headquartered in Baltimore, MD.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kurzius Lawrence Erik	10% Owner	Feb 12 '26	Option Exercise	49.02	50,000	2,451,250	346,992	Feb 13 12:05 PM
Kurzius Lawrence Erik	10% Owner	Feb 12 '26	Sale	71.63	50,000	3,581,500	296,992	Feb 13 12:05 PM
MANGAN MICHAEL D	Director	Feb 09 '26	Option Exercise	49.96	5,000	249,800	48,029	Feb 10 02:10 PM
MANGAN MICHAEL D	Director	Feb 09 '26	Sale	67.92	5,000	339,600	43,029	Feb 10 02:10 PM
MANGAN MICHAEL D	Director	Feb 05 '26	Option Exercise	49.96	5,000	249,800	46,780	Feb 09 03:50 PM
Tapiero Jacques	Director	Feb 05 '26	Option Exercise	49.96	5,000	249,800	36,596	Feb 09 03:41 PM
Tapiero Jacques	Director	Feb 05 '26	Sale	67.09	5,000	335,450	31,596	Feb 09 03:41 PM
Schwartz Jeffery D	Vice President, Gen Counsel	Feb 03 '26	Option Exercise	49.96	10,000	499,600	100,028	Feb 05 01:20 PM
Tapiero Jacques	Director	Feb 03 '26	Option Exercise	49.96	5,000	249,800	36,596	Feb 04 02:22 PM
Tapiero Jacques	Director	Feb 03 '26	Sale	63.85	5,000	319,250	31,596	Feb 04 02:22 PM
Tapiero Jacques	Director	Feb 02 '26	Option Exercise	61.10	6	348	31,596	Feb 03 12:30 PM
Kurzius Lawrence Erik	10% Owner	Jan 13 '26	Option Exercise	49.96	50,000	2,498,000	296,762	Jan 14 04:03 PM
Kurzius Lawrence Erik	10% Owner	Jan 13 '26	Sale	67.43	50,000	3,371,500	246,762	Jan 14 04:03 PM
Tapiero Jacques	Director	Jan 02 '26	Option Exercise	67.28	792	53,310	31,590	Jan 06 03:53 PM
Brendan Foley	Affiliate	Nov 13 '25	Proposed Sale	65.56	57,144	3,746,361		Nov 13 05:44 PM
Foley Brendan M	Chairman, President & CEO	Nov 12 '25	Option Exercise	49.96	57,144	2,854,914	165,796	Nov 13 04:43 PM
Foley Brendan M	Chairman, President & CEO	Nov 12 '25	Sale	65.56	57,144	3,746,361	108,652	Nov 13 04:43 PM
Kurzius Lawrence Erik	10% Owner	Nov 11 '25	Sale	64.54	39,014	2,517,964	0	Nov 12 12:13 PM
Kurzius Lawrence Erik	10% Owner	Oct 08 '25	Option Exercise	49.96	50,000	2,498,000	296,762	Oct 10 09:40 AM
Kurzius Lawrence Erik	10% Owner	Oct 08 '25	Sale	65.86	50,000	3,293,000	246,762	Oct 10 09:40 AM
Schwartz Jeffery D	Vice President, Gen Counsel	Jul 01 '25	Option Exercise	49.96	10,000	499,600	83,957	Jul 02 10:25 AM
Jenkins Katherine	Chief Growth Officer	May 12 '25	Option Exercise	49.62	5,430	269,413	3,430	May 13 03:17 PM
Jenkins Katherine	Chief Growth Officer	May 12 '25	Sale	76.38	7,642	583,696	0	May 13 03:17 PM
Repas Gregory	V.P. & Controller	Apr 03 '25	Sale	81.42	2,750	223,905	2,266	Apr 04 12:13 PM
Kurzius Lawrence Erik	Director	Apr 02 '25	Option Exercise	49.96	50,000	2,498,000	297,437	Apr 02 02:43 PM
Kurzius Lawrence Erik	Director	Apr 02 '25	Sale	81.81	50,000	4,090,300	247,437	Apr 02 02:43 PM
Montiel Maritza Gomez	Director	Apr 01 '25	Option Exercise	52.98	5,912	313,188	12,850	Apr 02 02:41 PM
Montiel Maritza Gomez	Director	Apr 01 '25	Sale	82.67	5,912	488,745	6,938	Apr 02 02:41 PM
Schwartz Jeffery D	Vice President, Gen Counsel	Mar 31 '25	Option Exercise	49.96	20,000	999,200	89,958	Apr 01 01:19 PM
Jenkins Katherine	Chief Growth Officer	Mar 15 '25	Option Exercise	0.00	584	0	2,309	Mar 18 06:32 PM
Gabriel Marcos Mendes	Executive VP & CFO	Mar 15 '25	Option Exercise	0.00	1,069	0	9,641	Mar 18 06:32 PM
Sanchez Ana	President EMEA	Mar 15 '25	Option Exercise	0.00	648	0	5,441	Mar 18 06:25 PM
Tapiero Jacques	Director	Mar 15 '25	Option Exercise	0.00	1,344	0	30,446	Mar 18 06:23 PM
Repas Gregory	V.P. & Controller	Mar 15 '25	Option Exercise	0.00	711	0	5,105	Mar 18 06:20 PM
Kurzius Lawrence Erik	Director	Mar 15 '25	Option Exercise	0.00	1,734	0	248,079	Mar 18 06:18 PM
Piper Sarah	Chief Human Relations Officer	Mar 15 '25	Option Exercise	0.00	212	0	3,331	Mar 18 06:14 PM
Foust Andrew	President, Americas	Mar 15 '25	Option Exercise	0.00	931	0	8,858	Mar 18 06:12 PM
THOMAS TERRY S	Director	Mar 15 '25	Option Exercise	0.00	1,344	0	1,734	Mar 18 06:10 PM
Montiel Maritza Gomez	Director	Mar 15 '25	Option Exercise	0.00	1,344	0	6,938	Mar 18 06:08 PM
PRESTON MARGARET M V	Director	Mar 15 '25	Option Exercise	0.00	1,344	0	81,293	Mar 18 06:07 PM
Conway Michael Aaron	Director	Mar 15 '25	Option Exercise	0.00	1,344	0	16,630	Mar 18 06:04 PM
BRAMMAN ANNE L	Director	Mar 15 '25	Option Exercise	0.00	1,344	0	6,639	Mar 18 06:01 PM
MANGAN MICHAEL D	Director	Mar 15 '25	Option Exercise	0.00	1,344	0	41,780	Mar 18 05:59 PM
LITTLE PATRICIA A	Director	Mar 15 '25	Option Exercise	0.00	1,344	0	26,076	Mar 18 05:58 PM
VERNON W ANTHONY	Director	Mar 15 '25	Option Exercise	0.00	1,344	0	11,826	Mar 18 05:56 PM
RODKIN GARY M	Director	Mar 15 '25	Option Exercise	0.00	1,344	0	12,110	Mar 18 05:54 PM

ELAN Elanco Animal Health Inc daily Stock Chart

Peers: ZTS IDXX ABT MRK SNY PETS BIIB VET RDFN

| Held by: IJH VTI VB VBR VXF MDY XMHQ DFAT IJK SPMD

Index	-	P/E	344.72	EPS (ttm)	0.07	Insider Own	0.92%	Shs Outstand	496.83M	Perf Week	-0.28%
Market Cap	12.49B	Forward P/E	24.50	EPS next Y	1.03	Insider Trans	0.96%	Shs Float	492.28M	Perf Month	2.82%
Enterprise Value	16.01B	PEG	3.07	EPS next Q	0.11	Inst Own	113.37%	Short Float	4.72%	Perf Quarter	13.97%
Income	36.00M	P/S	2.72	EPS this Y	2.53%	Inst Trans	3.12%	Short Ratio	4.61	Perf Half Y	39.61%
Sales	4.59B	P/B	1.85	EPS next Y	9.92%	ROA	0.27%	Short Interest	23.23M	Perf YTD	11.05%
Book/sh	13.58	P/C	24.73	EPS next 5Y	7.98%	ROE	0.54%	52W High	26.08 -3.62%	Perf Year	115.52%
Cash/sh	1.02	P/FCF	33.93	EPS past 3/5Y	- 29.95%	ROIC	0.34%	52W Low	8.02 213.34%	Perf 3Y	92.71%
Dividend Est.	-	EV/EBITDA	17.57	Sales past 3/5Y	-2.33% 7.65%	Gross Margin	43.32%	Volatility	2.93% 3.05%	Perf 5Y	-15.53%
Dividend TTM	-	EV/Sales	3.49	EPS Y/Y TTM	-82.39%	Oper. Margin	5.25%	ATR (14)	0.76	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.23	Sales Y/Y TTM	3.08%	Profit Margin	0.78%	RSI (14)	57.48	Recom	1.56
Dividend Gr. 3/5Y	- -	Current Ratio	2.40	EPS Q/Q	-109.35%	SMA20	1.93%	Beta	1.84	Target Price	26.42
Payout	0.00%	Debt/Eq	0.60	Sales Q/Q	10.39%	SMA50	7.47%	Rel Volume	0.66	Prev Close	24.79
Employees	9450	LT Debt/Eq	0.59	Earnings	Feb 24 BMO	SMA200	34.51%	Avg Volume	5.04M	Price	25.13
IPO	Sep 20, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	46.15% 4.14%	Trades		Volume	3,343,477	Change	1.37%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-22-26	Upgrade	Piper Sandler	Neutral → Overweight
Dec-09-25	Initiated	Barclays	Overweight	$30
Nov-21-25	Initiated	KeyBanc Capital Markets	Overweight	$27
Nov-19-25	Upgrade	Argus	Hold → Buy	$25
Oct-07-25	Upgrade	JP Morgan	Neutral → Overweight	$24
Jul-17-25	Upgrade	Leerink Partners	Market Perform → Outperform	$18
Jun-26-25	Upgrade	William Blair	Mkt Perform → Outperform
Dec-09-24	Initiated	UBS	Buy	$18
Dec-02-24	Initiated	Leerink Partners	Market Perform	$14
Sep-19-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$17 → $15
Jan-05-24	Upgrade	Stifel	Hold → Buy	$13 → $20
Dec-19-23	Initiated	Jefferies	Buy	$17
Dec-15-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$16
Dec-07-23	Initiated	Exane BNP Paribas	Outperform	$18
Apr-20-23	Upgrade	Barclays	Equal Weight → Overweight	$14
Aug-18-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$37 → $22
Aug-16-22	Downgrade	JP Morgan	Overweight → Neutral	$28 → $24
Jul-21-22	Downgrade	Goldman	Buy → Sell	$32 → $19
Jul-12-22	Initiated	Piper Sandler	Neutral	$22
Nov-18-21	Initiated	Morgan Stanley	Overweight	$40

Show Previous Ratings

Feb-13-26 09:24AM	Elanco Announces Updates to Board of Directors (PR Newswire)
Feb-10-26 06:41AM	Here's What the Street Thinks About Elanco Animal Health Incorporated (ELAN) (Insider Monkey)
Jan-30-26 11:56AM	Can Operational Execution Support DaVita's Q4 Performance? (Zacks)
Jan-28-26 07:50AM	Hardman Johnston Global Equity Strategy Initiated a Position in Elanco Animal Health (ELAN) (Insider Monkey)
Jan-27-26 04:04PM	Gold and Silver Arent the Only Hot Commodities. Agricultural Stocks to Consider. (Barrons.com)
11:35PM	Loading…
Jan-26-26 11:35PM	2 Profitable Stocks to Own for Decades and 1 Facing Headwinds (StockStory)
Jan-22-26 04:36PM	Stocks Settle Higher as Global Tensions Cool and the Economy Expands (Barchart)
08:00AM	Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2025 Financial Results Announcement (PR Newswire)
06:00AM	Companies Move to Refinance Sooner: Better Off to Lock It In (The Wall Street Journal)
Jan-12-26 06:54PM	Elanco CEO: Gaining Market Share Via 'Major' Innovations (Bloomberg)
Jan-06-26 11:08PM	3 Reasons to Avoid ELAN and 1 Stock to Buy Instead (StockStory)
06:52PM	Analyst Report: Elanco Animal Health Incorporated (Morningstar Research)
08:00AM	Elanco to Participate in the 44th Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-31-25 02:00PM	Elanco Receives USDA Approval for Befrena (tirnovetmab), a New Anti-IL31 Monoclonal Antibody Injection Targeting Canine Allergic and Atopic Dermatitis (PR Newswire)
Dec-21-25 10:07AM	Jim Cramer on Elanco Animal Health: "They Are Doing Everything Right" (Insider Monkey)
01:30AM	Loading…
Dec-19-25 01:30AM	Elanco CEO Bites Off More Shares of Fast-Rising Stock (Barrons.com)
Dec-18-25 08:43AM	Elanco's Credelio Quattro-CA1 (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Receives First FDA Conditional Approval for Treatment of New World Screwworm in Dogs (PR Newswire)
Dec-16-25 02:05PM	Elanco (ELAN) Stock Is Up, What You Need To Know (StockStory)
09:40AM	Are Medical Stocks Lagging Elanco Animal Health (ELAN) This Year? (Zacks)
Dec-12-25 12:00PM	All You Need to Know About Elanco Animal Health (ELAN) Rating Upgrade to Buy (Zacks)
Dec-09-25 04:15PM	How Protein And Pets Drove Elanco Animal Health's Double-Digit Gain In 2025 (Investor's Business Daily) -5.81%
07:40AM	Elanco Investor Day Defines New Era as Sustainable Growth Company (PR Newswire)
Nov-24-25 07:00PM	Elanco, AMN Healthcare Services, Brookdale, DexCom, and Addus HomeCare Shares Skyrocket, What You Need To Know (StockStory)
Nov-21-25 01:35PM	Elanco's Credelio CAT (lotilaner) Receives First FDA Emergency Use Authorization (EUA) for Treatment of New World Screwworm (NWS) in Cats (PR Newswire)
Nov-20-25 08:00AM	Elanco to Participate in the Upcoming Investor Conferences (PR Newswire)
Nov-14-25 09:03AM	Pet Healthcare Spending Is Soaring. These 5 Stocks Are Positioned to Clean Up (24/7 Wall St.)
Nov-13-25 08:00AM	Alloy Partners Launches OneHealth Studio to Create Startups at the Convergence of Animal, Plant and Human Health (PR Newswire)
Nov-12-25 12:35AM	5 Revealing Analyst Questions From Elanco's Q3 Earnings Call (StockStory)
Nov-11-25 08:46AM	Are Options Traders Betting on a Big Move in Elanco Animal Health Stock? (Zacks)
Nov-06-25 12:33AM	ELAN Q3 Deep Dive: Innovation Drives Growth, but Market Eyes Margin and Competition (StockStory)
07:26PM	Loading…
Nov-05-25 07:26PM	Analyst Report: Elanco Animal Health Incorporated (Morningstar Research)
03:12PM	Elanco Animal Health CEO: Seeing a willingness to spend, durability even in 'consumer tested' time (CNBC TV)
02:01PM	Elanco Animal Health Inc (ELAN) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
09:30AM	Compared to Estimates, Elanco Animal Health (ELAN) Q3 Earnings: A Look at Key Metrics (Zacks)
07:35AM	Elanco Animal Health Incorporated (ELAN) Q3 Earnings and Revenues Surpass Estimates (Zacks)
06:36AM	Elanco (NYSE:ELAN) Surprises With Q3 Sales (StockStory)
06:27AM	Elanco Animal Health Reports Third Quarter 2025 Results (PR Newswire)
Nov-03-25 10:19PM	Elanco (ELAN) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
04:28PM	How Idexx Laboratories Business Shook Off Bears And Hit A Record (Investor's Business Daily)
Oct-29-25 10:00AM	Elanco Animal Health Incorporated (ELAN) Reports Next Week: What You Should Expect (Zacks)
Oct-28-25 11:27AM	Can Technology and Cost Discipline Lift DaVita's Q3 Earnings? (Zacks)
Oct-27-25 06:27AM	Elanco Announces Expansion of Credelio Quattro (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) and Credelio (lotilaner) Labels, Offering Protection Against Lyme Disease and an Emerging Tick Species (PR Newswire)
Oct-24-25 05:33PM	Elanco Animal Health Obtains FDA Authorization for Screwworm Treatment (The Wall Street Journal)
04:55PM	Elanco's Credelio (lotilaner) Receives First Ever FDA Emergency Use Authorization (EUA) against New World Screwworm (NWS) in Dogs (PR Newswire)
12:02AM	Elanco (ELAN): Buy, Sell, or Hold Post Q2 Earnings? (StockStory)
Oct-23-25 11:40AM	ELAN vs. USPH: Which Stock Is the Better Value Option? (Zacks)
Oct-22-25 09:40AM	Is Elanco Animal Health (ELAN) Stock Outpacing Its Medical Peers This Year? (Zacks)
Oct-20-25 02:03PM	West Pharmaceutical Services Stock Sees RS Rating Climb To 71 (Investor's Business Daily)
Oct-17-25 06:39PM	Analyst Report: Elanco Animal Health Incorporated (Morningstar Research)
Oct-16-25 04:32PM	Elanco to Host Investor Day on December 9 (PR Newswire)
Oct-08-25 12:00PM	Elanco Animal Health Incorporated (ELAN) is a Great Momentum Stock: Should You Buy? (Zacks)
Oct-07-25 11:31AM	Why Elanco (ELAN) Stock Is Trading Up Today (StockStory)
Oct-06-25 11:40AM	ELAN or USPH: Which Is the Better Value Stock Right Now? (Zacks)
05:15AM	Best Value Stocks to Buy for October 6th (Zacks)
Oct-01-25 08:00AM	Elanco Confirms Date and Conference Call for Third Quarter 2025 Financial Results Announcement (PR Newswire)
Sep-30-25 12:00PM	Elanco Animal Health (ELAN) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Sep-24-25 12:01PM	Why Elanco (ELAN) Stock Is Up Today (StockStory)
Sep-23-25 07:10PM	Elanco Animal Health Incorporated (ELAN) Joins S&P MidCap 400 Following Strong Q2 Growth and Product Ramp-Up (Insider Monkey)
06:27AM	Elanco Announces FDA Approves Improved Zenrelia (ilunocitinib tablets) Label, Removing Vaccine-Induced Disease Language (PR Newswire)
Sep-11-25 10:57PM	Analyst Report: Elanco Animal Health Incorporated (Morningstar Research)
Sep-08-25 03:35PM	Why Elanco (ELAN) Stock Is Trading Up Today (StockStory)
06:27AM	Elanco Innovation Builds Momentum, Credelio Quattro (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Reaches Blockbuster Status (PR Newswire)
Sep-03-25 02:45PM	Why Elanco (ELAN) Stock Is Trading Lower Today (StockStory)
Sep-01-25 11:31PM	Unpacking Q2 Earnings: Elanco (NYSE:ELAN) In The Context Of Other Pharmaceuticals Stocks (StockStory)
Aug-27-25 12:31PM	Why Elanco (ELAN) Stock Is Trading Up Today (StockStory)
08:00AM	Splenda Joins Elanco and HATCH to Support 'Nutrition Secure Indianapolis' to Strengthen Family Health Through Nutrition and Education (PR Newswire)
Aug-26-25 06:15PM	Elanco Animal Health Set to Join S&P MidCap 400; Sarepta Therapeutics to Join S&P SmallCap 600 (PR Newswire)
08:00AM	Elanco to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference (PR Newswire)
Aug-14-25 01:34AM	5 Insightful Analyst Questions From Elanco's Q2 Earnings Call (StockStory)
Aug-12-25 03:25AM	ELAN Q2 Deep Dive: Innovation and Execution Drive Raised Full-Year Outlook (StockStory)
Aug-08-25 06:57PM	Analyst Report: Elanco Animal Health Incorporated (Morningstar Research)
11:53AM	Elanco (ELAN) Jumps 19.7% to Record High on Earnings Boost (Insider Monkey)
Aug-07-25 02:13PM	Elanco (NYSE:ELAN) Delivers Impressive Q2, Stock Jumps 15.4% (StockStory) +18.14%
12:23PM	Elanco Animal Health Soars Past 52-Week High On Strong Sales, Raised Annual Outlook (Benzinga)
09:30AM	Elanco Animal Health (ELAN) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
07:35AM	Elanco Animal Health Incorporated (ELAN) Q2 Earnings and Revenues Beat Estimates (Zacks)
06:59AM	Elanco Animal Health Raises 2025 Guidance (RTT News)
06:27AM	Elanco Animal Health Reports Second Quarter 2025 Results (PR Newswire)
Aug-06-25 06:15PM	U.S. Physical Therapy (USPH) Tops Q2 Earnings and Revenue Estimates (Zacks)
09:15AM	Curious about Elanco Animal Health (ELAN) Q2 Performance? Explore Wall Street Estimates for Key Metrics (Zacks)
Aug-05-25 11:11PM	What To Expect From Elanco's (ELAN) Q2 Earnings (StockStory)
Aug-04-25 05:45PM	Addus HomeCare (ADUS) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
Jul-31-25 01:16PM	Can Phosphate Binders Drive DaVita Stock Before Q2 Earnings? (Zacks)
Jul-25-25 03:36PM	Why Elanco (ELAN) Stock Is Trading Up Today (StockStory)
Jul-24-25 05:42PM	Elanco Secures Approval of Zenrelia (ilunocitinib) in the European Union (EU), Launching Innovative Canine Dermatology Treatment for Itchy Dogs (PR Newswire)
11:40AM	ELAN vs. USPH: Which Stock Is the Better Value Option? (Zacks)
Jul-22-25 09:40AM	Are Medical Stocks Lagging Encompass Health (EHC) This Year? (Zacks)
Jul-21-25 04:11AM	Veterinary Dermatology - Company Evaluation Report 2025 \| Zoetis, Elanco, and Boehringer Ingelheim Dominate with Global Reach, Innovative Portfolios, and Strategic Expansion (GlobeNewswire)
Jul-17-25 09:46AM	Starbucks downgraded, Oracle initiated: Wall Street's top analyst calls (The Fly)
Jul-15-25 10:35AM	Are Options Traders Betting on a Big Move in ELAN Stock? (Zacks)
Jul-10-25 08:00AM	Elanco Confirms Date and Conference Call for Second Quarter 2025 Financial Results Announcement (PR Newswire)
Jul-09-25 08:27AM	Elanco Receives USDA Approval for TruCan Ultra CIV H3N2/H3N8 (Canine Influenza Vaccine) Bringing to Market a High Standard of Respiratory Protection (PR Newswire)
Jul-02-25 07:00AM	Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001 (PR Newswire)
Jun-30-25 07:25AM	5 Revealing Analyst Questions From Elanco's Q1 Earnings Call (StockStory)
Jun-26-25 01:00PM	Elanco Releases 2024 Impact Report and Introduces New Framework (PR Newswire)
09:49AM	General Mills upgraded, Trade Desk downgraded: Wall Street's top analyst calls (The Fly)
Jun-18-25 12:46PM	Zoetis Stock Is Falling. Why the Animal-Health Company Was Downgraded. (Barrons.com)
Jun-12-25 04:17PM	Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from EU's Committee for Veterinary Medicinal Products (CVMP) (PR Newswire)
Jun-11-25 04:25AM	ELAN Q1 Earnings Call: Innovation and Product Launches Drive Outlook Amid Macro Uncertainty (StockStory)
Jun-10-25 12:00PM	What Makes Elanco Animal Health (ELAN) a New Buy Stock (Zacks)

Elanco Animal Health, Inc. develops, manufactures, and markets products for pets and farm animals. Its products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, TruCan, AviPro, Baytril, Catosal, Denagard, and Experior. The company was founded in 1954 and is headquartered in Indianapolis, IN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kurzius Lawrence Erik	Director	Dec 12 '25	Buy	21.30	10,000	213,000	131,773	Dec 16 04:42 PM
Modi Rajeev A.	SEE REMARKS	Dec 11 '25	Buy	21.33	4,500	95,985	123,082	Dec 15 04:43 PM
VanHimbergen Robert M	EVP and CFO	Dec 11 '25	Buy	21.64	6,950	150,426	124,233	Dec 15 04:42 PM
Simmons Jeffrey N	PRESIDENT, CEO AND DIRECTOR	Dec 11 '25	Buy	21.75	22,000	478,496	167,000	Dec 15 04:41 PM
Todd S and Jennifer G Young Li	Former CFO	Aug 11 '25	Proposed Sale	16.82	49,333	830,000		Aug 11 03:58 PM
Kurzius Lawrence Erik	Director	Mar 07 '25	Buy	10.90	10,000	109,000	101,459	Mar 11 05:13 PM
Kurzius Lawrence Erik	Director	Mar 11 '25	Buy	10.20	10,000	102,000	111,459	Mar 11 05:13 PM
HOOVER R DAVID	Director	Mar 05 '25	Buy	10.90	25,000	272,558	210,000	Mar 07 04:21 PM

COO

Cooper Companies, Inc

MKC

McCormick & Co., Inc

ELAN

Elanco Animal Health Inc

Upgrade your FINVIZ experience